Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome
Antonella Tramutola(Sapienza University of Rome), Fabio Di Domenico(Sapienza University of Rome)
Cited by 100
Related Papers
Brain insulin resistance triggers early onset Alzheimer disease in Down syndrome
|Neurobiology of Disease|2020|70
Restoration of aberrant mTOR signaling by intranasal rapamycin reduces oxidative damage: Focus on HNE-modified proteins in a mouse model of down syndrome
|Redox Biology|2019|67
Shaping down syndrome brain cognitive and molecular changes due to aging using adult animals from the Ts66Yah murine model
|Neurobiology of Disease|2024|14